NeonMind Biosciences Overview
- Year Founded
-
2019
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
1
NeonMind Biosciences General Information
Description
Lancaster resources Inc is engaged in exploring energy transition metals, particularly lithium, to take advantage of the global shift towards decarbonization and electrification. Its goal is to identify, acquire, explore, and develop high-quality mineral-rich properties, integrating sustainable energy sources and innovative technologies for climate-positive resource production. The Company holds exclusive rights to acquire a 100% interest in the Alkali Flat lithium brine project situated in Lordsburg, New Mexico, USA.
Contact Information
Website
www.neonmindbiosciences.comCorporate Office
- 5 - 519 Dundas Street West
- Suite 511
- Oakville, Ontario L6M 5K3
- Canada
Corporate Office
- 5 - 519 Dundas Street West
- Suite 511
- Oakville, Ontario L6M 5K3
- Canada
NeonMind Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
NeonMind Biosciences Patents
NeonMind Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021243461-A1 | Use of lsd, esa, or dmt for weight loss. | Inactive | 04-Jun-2020 | ||
| WO-2021243460-A1 | Method for weight loss with therapy | Inactive | 03-Jun-2020 | ||
| WO-2021159213-A1 | Method for producing an extract of mushroom and mushroom extract made therefrom | Inactive | 12-Feb-2020 | ||
| CA-3160793-A1 | Use of psilocin, psilocybin or analogs thereof in weight loss, treatment of obesity and compulsive eating disorder | Pending | 04-Dec-2019 | ||
| US-20230021957-A1 | Use of psilocin, psilocybin or analogs thereof in weight loss, treatment of obesity and compulsive eating disorder | Inactive | 04-Dec-2019 | A61K31/675 |
NeonMind Biosciences Investments (1)
NeonMind Biosciences’s most recent deal was a Corporate with Translational Life Sciences for . The deal was made on 04-Feb-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Translational Life Sciences | 04-Feb-2020 | Corporate | Drug Discovery |
NeonMind Biosciences Exits (1)
NeonMind Biosciences’s most recent exit was on 04-Feb-2020 from Translational Life Sciences. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Translational Life Sciences | 04-Feb-2020 | Completed |
|
NeonMind Biosciences FAQs
-
When was NeonMind Biosciences founded?
NeonMind Biosciences was founded in 2019.
-
Where is NeonMind Biosciences headquartered?
NeonMind Biosciences is headquartered in Oakville, Canada.
-
What industry is NeonMind Biosciences in?
NeonMind Biosciences’s primary industry is Drug Discovery.
-
Is NeonMind Biosciences a private or public company?
NeonMind Biosciences is a Private company.
-
What is NeonMind Biosciences’s current revenue?
The current revenue for NeonMind Biosciences is .
-
How much funding has NeonMind Biosciences raised over time?
NeonMind Biosciences has raised $3.6M.
-
When was NeonMind Biosciences acquired?
NeonMind Biosciences was acquired on 09-Jun-2023.
-
Who acquired NeonMind Biosciences?
NeonMind Biosciences was acquired by Lancaster Resources.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process